GAVI: Alliance Partners Forum
5-7 December 2012, Dar es Salaam, Tanzania
More than 650 global health and government leaders exploring ways to accelerate Results, Innovation, Sustainability and Equity [RISE] in the field of immunisation.

This page – http://www.gavialliance.org/forum/ – provides a single, integrated source of content associated with the Forum. Please see Seth Berkley’s opening plenary excerpts just below and, further below, media releases issued by GAVI during the week.

Speech: GAVI Past, Present and Future – GAVI CEO Seth Berkley
Excerpts from GAVI

PAST
About the Baobab tree, the Forum’s symbol: “the baobab tree has a special significance in Africa. It’s revered. People gather under its branches to discuss important issues and talk to their ancestors. This Forum is a time for us to come together and discuss. We should start with our founders and the question is how are we doing. I think we are living up to their vision. As of 2014, every single GAVI country will be using the DTP3 vaccine. It is a routine vaccine and that is what we are trying to do.”

PRESENT
Rollout of pneumococcal vaccine: it‘s an extraordinary story that this vaccine (pneumococcal) was made available in developing countries about a year and a half after it became available in high-income countries. The ultimate goal would be simultaneous introduction in north and south. That’s what we want. Never again will a company have a life-saving vaccine and ask ‘when’ will it reach a developing country. The question should only be ‘how’.

On the heroic efforts of health workers in developing countries: health workers do whatever it takes to get the vaccines out there … camels, donkeys .. It’s heroic. It’s getting the vaccine into her hands so she can vaccinate and it’s going to lead to healthy children in school.”

FUTURE
The fully immunised child: WHO recommends that every child has 11 antigens: BCG, DTP3 (diphtheria-tetanus-pertussis), measles, polio, hepatitis B, Haemophilus influenzae type b, pneumococcal, rotavirus, rubella and human papillomavirus.

So should we be looking at DTP3 or the fully immunised child as an indicator of immunisation coverage? What we want is every child, everywhere protected by the full number of antigens.     Conceptually, this is where we want to go. If we want to do this, current estimates predict that by 2030, only 50 percent of children will be fully immunised. This is not good enough; we need to reset our aspirations.

Technology: we also need to use technology. Every village household has one cell phone in it and often two or more. Why is it that we are not looking at vaccine stock using GPS, so a flashing red light on an interactive map tells us immediately there is a stock problem in a local health clinic. This is not far fetched. This is what is happening in most of the world for supply chains. We just haven’t used it in immunisation.

Inconsistency in immunisation data: can we measure immunisation rates? Our numbers really aren’t very tight. We’re shooting in the dark against a target, because we don’t have the tools to really allow us to understand what is happening. This is a critical goal going forward.

Flowering of our effort: when we think about the field of immunisation, we’re back to the (baobab) tree. We need to bring together all the critical parts of immunisation, to become part of routine immunisation. Something extraordinary will happen, we will see the flowering of this effort, and we will see something extraordinary happen.

Watch the video of GAVI CEO, Seth Berkley presenting his visionary speech:
http://www.gavialliance.org/library/news/gavi-features/2012/past-present-future-plenary/

Media Releases during the week of the Alliance Partners’ Forum:
06 December 2012
More than 30 million girls to be immunised with HPV vaccines by 2020 with GAVI support
The GAVI Alliance plans to work with countries to prepare them for nationwide roll outs of the vaccine against the human papillomavirus (HPV), the leading cause of cervical cancer.

05 December 2012
Immunisation protecting 370 million additional children through successful global partnership
Progress is accelerating in the global effort to protect children from infectious diseases and spread the benefits of immunisation around the world.

04 December 2012
GAVI Board reappoints Dagfinn Høybråten as chair
The GAVI Alliance Board unanimously reappointed Dagfinn Høybråten to serve a second-year term as the GAVI Board Chair.

03 December 2012
100 millionth person receives lifesaving meningitis vaccine
A revolutionary meningitis vaccine will reach the 100 millionth person this week in a region of Africa that has been plagued by deadly epidemics for more than a century. The milestone will take place in northern Nigeria, part of Africa’s “meningitis belt’, where the country is conducting its second seasonal immunisation campaign against the disease